期刊文献+

结核分支杆菌抗原ESAT-6真核表达质粒在COS-7中的表达 被引量:1

The Expression of Eukaryotic Expression Recombinant Plasmid of ESAT-6 from Mycobacterium Tuberculosis in COS-7 Cells
下载PDF
导出
摘要 目的 探讨结核分支杆菌早期分泌性抗原靶ESAT -6基因真核表达重组质粒在真核细胞 (COS -7)中的表达。 方法 用LipofectAMINETM2 0 0 0介导真核表达重组质粒 pcDNA3 .1(+ ) -ESAT -6转染真核细胞COS -7,72h后 ,通过RT -PCR和WesternBlotting试验鉴定ESAT -6基因在COS -7中的表达。  结果 通过RT -PCR从转染了pcDNA3 .1(+ ) -ESAT -6的COS -7中检测到目的基因mRNA的转录 ;WesternBlotting试验鉴定在转染pcDNA3 .1(+ ) -ESAT -6的COS -7的细胞裂解上清液中有ESAT -6基因的表达蛋白。 结论 结核杆菌早期分泌性蛋白ESAT -6真核表达重组质粒能够在真核细胞COS -7中表达ESAT -6蛋白 ,为进一步研究其特性及为结核病的诊断。 Objective To investigate transient expression of eukaryotic expression plasmid of ESAT-6 in eukaryotic cells(COS-7). Methods Eukaryotic expression plasmid pcDNA3.1(+)-ESAT-6 were transfected into eukaryotic cells(COS-7), and the transient expression of ESAT-6 gene in eukaryotic cells was detected by RT-PCR and Western Blotting. Result Transient expression of gene ESAT-6 in eukaryotic cells(COS-7) was confirmed by RT-PCR and Western Blotting. Conclusion The recombinant eukaryotic expression plasmid pcDNA3.1(+)-ESAT-6 expressed successfully in eukaryotic cells(COS-7).It lays the foudation for diagnosis and using of new vaccine of tuberculosis and the detecting of immunity effectiveness.
出处 《实用预防医学》 CAS 2003年第6期899-901,共3页 Practical Preventive Medicine
关键词 结核分支杆菌 早期分泌性抗原靶 真核表达质粒 表达蛋白 Mycobacterium tuberculosis Early secreted antigenic target Eukaryotic expression plasmid Transient expression
  • 相关文献

参考文献7

二级参考文献31

  • 1B.Q. Jiang, L. Gu,W.L. Zhang,Y.S. Sun and F. Lin Chemical Engineering Department of Nanchang University, Nanchang 330029, China.PREPARATION OF SILICA MOLECULAR SIEVE MEMBRANE FOR HYDROGEN SEPARATION[J].Acta Metallurgica Sinica(English Letters),1999,12(5):1077-1081. 被引量:1
  • 2刘启光,吴旻.脂质体作为基因工程载体的研究[J].生物化学与生物物理进展,1989,16(6):426-429. 被引量:5
  • 3张立兴,屠德华,阚冠卿.国际结核病流行出现的严重问题和我们的对策[J].中国防痨杂志,1996,18(3):97-100. 被引量:35
  • 4Nunn. P.The global epidemic the present epidemiology of tuberculosis. Scot Med J 2000,45 (Suppl 1) :6-7.
  • 5Dixie E S.Tuberculosis: the world situation. History of the disease and efforts to combat it. Tuberculosis: Back to the Future, 13- 33.
  • 6Dye C.Tuberculosis 2000 - 2010: control,but not elimination. Int J Tub Lung Dis, 4(12) :S146- S152.
  • 7Kochi A.The global tuberculosis situation and the new contral strategy of the World Health Organization. Tubercle, 1991, 72:1-6.
  • 8Tuberclosis in the world, World TB Day,Year 2000, International union against tuberculosis and lung disease, 2000.
  • 9Menzies D.Tuberculosis crosses borders. Int J Tuber Lung Dis4 (12) :S153-S159.
  • 10Zhang LX, Duanmu HJ, Tu DH. Achievements and perspectives of the tuberculosis control prograrms in China. Scot Med J 2000,45 (Suppl 1) :8- 10.

共引文献81

同被引文献18

  • 1宫强,刘思国,王牟平,王春来,彭永刚,沈国顺.结核分枝杆菌分泌蛋白ESAT-6、CFP10基因的克隆、鉴定及其原核表达[J].中国兽医学报,2004,24(4):340-342. 被引量:4
  • 2王世若 王兴龙 韩文瑜 等.现代动物免疫学[M].长春:吉林科学技术出版社,2001.73-75.
  • 3Bloom B.R., and Muurray C.J.Tuberculosis:dommentary on a reemergent killer[J].Science, 1992,257:1055-1064.
  • 4Colditz G.A.Brewer T.F, Berkey C.S, Bordich M.E, Fineberg H.V, and Mosteller F, Efficacy of BCG vaccine in the preven tion of tuberculosis:meta analysis of the published literature, JAMA [M]. 1994,271:698-702.
  • 5Cole S T, Brosch R, Parkhill J, Gamier T, Churcher C, Harris D,Gordon S V,Eiglmeier K,Gas S,Barry C E,Tekaia F, Badcock K,Basham D,Brown D,Chillingworth T,Cormor R,Davies R,Devlin K,FeltweU T,Gentles S,Hamlin N, Holroyd S,Hornsby T,Jagels K,Kroghs A,McLean J, Moule S,Murphy L,Oliver K, Osborne J,Quail M A, Rafandream M A, Rogers J, Rutter S, Seeger K, Skelton J, Squaraes R, Squares S, Sulston J E, Taylo K, Whitehead S, Barrell B G.Deciphering the biology of My cobacterium tuberculosis from the complete genome sequence [J].Nature, 1998,393:537-544.
  • 6Horwitz M.A,Lee B.W.,Dillon B.J. ,and Harth G.,Protective immunity against tuberculosis induced by vaccination with major extraceUular proteins of Mycobacterium tuberculosis, [J]. Proc.Natl.Acad.Sci .,USA 1995,92:1530-1534.
  • 7Huygen K., Content J., and Denis O., Immunogenicity and protective efficacy of a tuberculosis DNA vaccine [J].Nat. Med., 1996,2:857-859.
  • 8Ski θ t R.L.V., Oettinger T., and Rosenkrands I., Comparative evaluation of low-molecular-mass proteins from Mycobac terium tuberculosis identifies of the ESAT-6 family as im munodominant T-cell antigens [J]. Infect.Immun, 2000, 68: 214-220.
  • 9Harboe M., Oettinger T., and Wiker HlG., Rosenkrands I., an dAndersen P., Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG [J]. Infect.Immun, 1996,64:16-22.
  • 10Lowrie D. B., Silva C. L., and Colston M.J., Protection against tuberculosis by a plasmid DNA vaccine[J].Vaccine, 1997,15:834-838.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部